Adaptimmune Therapeutics
ADAP
#8446
Rank
ยฃ0.12 B
Marketcap
ยฃ0.48
Share price
0.82%
Change (1 day)
22.19%
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2024 (TTM): -ยฃ34.09 Million

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are ยฃ0.17 Billion. In 2023 the company made an earning of -ยฃ89.18 Million, an increase over its 2022 earnings that were of -ยฃ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adaptimmune Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ34.09 Million-61.78%
2023 -ยฃ89.18 Million-30.65%
2022 -ยฃ0.13 Billion-0.36%
2021 -ยฃ0.13 Billion21.62%
2020 -ยฃ0.11 Billion-4.55%
2019 -ยฃ0.12 Billion69%
2018 -ยฃ65.79 Million-7.47%
2017 -ยฃ71.1 Million24.71%
2016 -ยฃ57.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ0.21 Billion 495.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ7.81 Million-77.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.22 Billion 508.72%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ0.47 B-1,456.61%๐Ÿ‡บ๐Ÿ‡ธ USA